Screener
Axsome Therapeutics AXSM Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Plus components not separately reported this period.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's total debt?
- Axsome Therapeutics (AXSM) reported total debt of $219.9M in Q1 2026.
- How has Axsome Therapeutics's total debt changed year-over-year?
- Axsome Therapeutics's total debt increased by 4.1% year-over-year, from $211.23M to $219.9M.
- What is the long-term trend for Axsome Therapeutics's total debt?
- Over 5 years (2020 to 2025), Axsome Therapeutics's total debt has grown at a 34.2% compound annual growth rate (CAGR), from $50.12M to $218.11M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Axsome Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude